ORAMED PHARMACEUTICALS INC. Quarterly Lessee, Operating Lease, Liability, to be Paid in USD from Q2 2021 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease.
Summary
Oramed Pharmaceuticals Inc. quarterly Lessee, Operating Lease, Liability, to be Paid history and growth rate from Q2 2021 to Q2 2024.
  • Oramed Pharmaceuticals Inc. Lessee, Operating Lease, Liability, to be Paid for the quarter ending June 30, 2024 was $505K, a 33.5% decline year-over-year.
Lessee, Operating Lease, Liability, to be Paid, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $505K -$254K -33.5% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $545K -$302K -35.7% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $634K -$310K -32.8% Dec 31, 2023 10-Q 2024-08-14
Q3 2023 $667K -$284K -29.9% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $759K -$277K -26.7% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $847K -$97K -10.3% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $944K +$416K +78.8% Dec 31, 2022 10-Q 2023-11-09
Q3 2022 $951K +$386K +68.3% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $1.04M +$440K +73.8% Jun 30, 2022 10-Q 2022-08-10
Q1 2022 $944K Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $528K Dec 31, 2021 10-Q 2022-11-10
Q3 2021 $565K Aug 31, 2021 10-QT 2022-03-30
Q2 2021 $596K May 31, 2021 10-Q 2021-07-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.